Abstract |
The aim of this study was to investigate the antiproliferative effects of C-1311 (Symadex), a member of the imidazoacridinone family, in human colorectal cancer cells. In the in vitro screen, C-1311 led to the most prominent growth inhibition in HT29, HCT116, and COLO205 cell lines when compared to oxaliplatin, CPT-11, DFUR, 5-FU and capecitabine. The GI(50)values for C-1311 ranged from 0.12 to 0.83 microM and the TGI concentrations (resulting in total growth inhibition) were 6- to 13-fold lower than those of other agents. In the hollow fiber assay in vivo, C-1311 caused 77% growth inhibition of HT29 in the intraperitoneal site as compared to paclitaxel (17% growth inhibition). In the subcutaneous site, C-1311 produced 57% growth inhibition while paclitaxel showed no cell growth inhibition effects. This unique cytotoxicity profile of C-1311 warrants further investigation and supports its clinical development in colon cancer patients. Symadex (C-1311) is currently in phase 2 clinical trials.
|
Authors | N Alami, J Paterson, S Belanger, S Juste, C K Grieshaber, B Leyland-Jones |
Journal | Journal of chemotherapy (Florence, Italy)
(J Chemother)
Vol. 19
Issue 5
Pg. 546-53
(Oct 2007)
ISSN: 1120-009X [Print] England |
PMID | 18073154
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Aminoacridines
- Antineoplastic Agents
- Organoplatinum Compounds
- Oxaliplatin
- Deoxycytidine
- Capecitabine
- Irinotecan
- C 1311
- Paclitaxel
- Fluorouracil
- Camptothecin
|
Topics |
- Aminoacridines
(chemistry, pharmacology)
- Animals
- Antineoplastic Agents
(chemistry, pharmacology)
- Camptothecin
(analogs & derivatives, pharmacology)
- Capecitabine
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Clinical Trials, Phase II as Topic
- Colonic Neoplasms
(drug therapy)
- Deoxycytidine
(analogs & derivatives, pharmacology)
- Drug Screening Assays, Antitumor
- Fluorouracil
(analogs & derivatives, pharmacology)
- HT29 Cells
- Humans
- In Vitro Techniques
- Irinotecan
- Mice
- Mice, Nude
- Organoplatinum Compounds
(pharmacology)
- Oxaliplatin
- Paclitaxel
(pharmacology)
|